Harding Loevner LP Has Lowered Its Microsoft (MSFT) Position; HCA Healthcare, Inc. (HCA) Covered By 20 Bullish Analysts Last Week

April 19, 2018 - By Marie Mckinney

HCA Healthcare, Inc. (NYSE:HCA) Logo

Harding Loevner Lp decreased Microsoft Corp (MSFT) stake by 47.47% reported in 2017Q4 SEC filing. Harding Loevner Lp sold 1.25 million shares as Microsoft Corp (MSFT)’s stock rose 4.63%. The Harding Loevner Lp holds 1.38 million shares with $118.13 million value, down from 2.63M last quarter. Microsoft Corp now has $740.18 billion valuation. The stock decreased 0.32% or $0.31 during the last trading session, reaching $96.13. About 1.92 million shares traded. Microsoft Corporation (NASDAQ:MSFT) has risen 37.43% since April 19, 2017 and is uptrending. It has outperformed by 25.88% the S&P500.

Among 30 analysts covering HCA Holdings (NYSE:HCA), 20 have Buy rating, 2 Sell and 8 Hold. Therefore 67% are positive. HCA Holdings had 100 analyst reports since August 6, 2015 according to SRatingsIntel. The company was maintained on Thursday, October 19 by Bank of America. The stock of HCA Healthcare, Inc. (NYSE:HCA) earned “Buy” rating by RBC Capital Markets on Sunday, August 27. The firm has “Buy” rating given on Friday, August 14 by Mizuho. The firm earned “Neutral” rating on Wednesday, July 26 by Bank of America. The stock has “Buy” rating by J.P. Morgan on Thursday, November 30. The rating was maintained by SunTrust on Wednesday, December 20 with “Buy”. The rating was maintained by Mizuho on Thursday, October 22 with “Buy”. Piper Jaffray maintained it with “Buy” rating and $9200 target in Tuesday, July 25 report. The stock of HCA Healthcare, Inc. (NYSE:HCA) has “Neutral” rating given on Friday, October 2 by Citigroup. The firm has “Hold” rating by Evercore given on Friday, September 23. See HCA Healthcare, Inc. (NYSE:HCA) latest ratings:

22/03/2018 Broker: Mizuho Rating: Buy New Target: $115.0000 Maintain
01/02/2018 Broker: BMO Capital Markets Old Rating: Outperform New Rating: Outperform Old Target: $96 New Target: $115 Maintain
01/02/2018 Broker: Morgan Stanley Old Rating: Underweight New Rating: Underweight Old Target: $84 New Target: $91 Maintain
31/01/2018 Broker: Jefferies Rating: Buy New Target: $118.0 Maintain
30/01/2018 Broker: RBC Capital Markets Rating: Buy New Target: $117.0 Maintain
31/01/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $115 New Target: $122 Maintain
31/01/2018 Broker: Leerink Swann Old Rating: Outperform New Rating: Outperform Old Target: $105 New Target: $120 Maintain
30/01/2018 Broker: SunTrust Rating: Buy New Target: $120.0 Maintain
30/01/2018 Broker: Robert W. Baird Rating: Buy New Target: $114.0 Maintain
30/01/2018 Broker: Piper Jaffray Rating: Hold New Target: $101.0 Maintain

The stock decreased 0.29% or $0.29 during the last trading session, reaching $98.44. About 54,720 shares traded. HCA Healthcare, Inc. (NYSE:HCA) has risen 7.67% since April 19, 2017 and is uptrending. It has underperformed by 3.88% the S&P500.

Since October 17, 2017, it had 2 buys, and 18 selling transactions for $55.29 million activity. 8,335 shares were sold by Cuffe Michael S., worth $810,680 on Wednesday, February 7. Another trade for 5,000 shares valued at $504,664 was made by Torres Kathryn A. on Wednesday, January 31. 119,637 HCA Healthcare, Inc. (NYSE:HCA) shares with value of $11.98 million were sold by Hall Charles J. $3.93 million worth of HCA Healthcare, Inc. (NYSE:HCA) was sold by Perlin Jonathan B. HAZEN SAMUEL N sold $5.63 million worth of stock. YUSPEH ALAN R had sold 15,000 shares worth $1.51M. The insider FRIST PATRICIA C bought $2.90M.

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States and England. The company has market cap of $34.67 billion. The firm operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services. It has a 16.54 P/E ratio. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling.

Investors sentiment decreased to 0.78 in 2017 Q4. Its down 0.01, from 0.79 in 2017Q3. It dropped, as 53 investors sold HCA Healthcare, Inc. shares while 199 reduced holdings. 75 funds opened positions while 121 raised stakes. 250.97 million shares or 4.23% less from 262.04 million shares in 2017Q3 were reported. Franklin Resources owns 16,755 shares for 0% of their portfolio. Bancorporation Of Montreal Can invested in 175,312 shares or 0.01% of the stock. Magellan Asset Ltd reported 16.66M shares. 35 were reported by Westend Advisors Ltd Company. Bb&T Corporation holds 100,788 shares. Lsv Asset Management stated it has 4.96 million shares or 0.69% of all its holdings. Paradigm Asset Com Limited Liability Company has invested 0.2% in HCA Healthcare, Inc. (NYSE:HCA). Rbf Cap Limited accumulated 75,000 shares or 0.73% of the stock. Fjarde Ap has 0.11% invested in HCA Healthcare, Inc. (NYSE:HCA). Price T Rowe Associate Md holds 5.21M shares. Service Automobile Association accumulated 139,908 shares or 0.03% of the stock. Everence Cap Mngmt accumulated 4,410 shares. North Carolina-based Piedmont Advsrs Ltd Liability Corporation has invested 0.11% in HCA Healthcare, Inc. (NYSE:HCA). Pura Vida Invs Limited Liability invested in 2.93% or 45,000 shares. Oregon Employees Retirement Fund reported 30,881 shares.

Analysts await Microsoft Corporation (NASDAQ:MSFT) to report earnings on April, 26 after the close. They expect $0.85 EPS, up 16.44% or $0.12 from last year’s $0.73 per share. MSFT’s profit will be $6.54 billion for 28.27 P/E if the $0.85 EPS becomes a reality. After $0.96 actual EPS reported by Microsoft Corporation for the previous quarter, Wall Street now forecasts -11.46% negative EPS growth.

Investors sentiment decreased to 0.77 in Q4 2017. Its down 0.06, from 0.83 in 2017Q3. It dived, as 39 investors sold MSFT shares while 1012 reduced holdings. 134 funds opened positions while 676 raised stakes. 5.46 billion shares or 0.90% less from 5.51 billion shares in 2017Q3 were reported. Pictet North America Advsrs Sa stated it has 128,338 shares. Cambridge accumulated 2.89% or 534,260 shares. Selz Capital Limited Com stated it has 2.53% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). First City Cap Mngmt reported 34,732 shares or 2.03% of all its holdings. Bartlett And Com Limited Liability Corporation accumulated 824,504 shares. Atria Investments Ltd invested in 157,097 shares or 0.67% of the stock. 149,389 were reported by Mairs & Pwr Inc. 35,698 were reported by Signalpoint Asset Mngmt Llc. Pinnacle Advisory Grp Inc holds 0.1% of its portfolio in Microsoft Corporation (NASDAQ:MSFT) for 20,809 shares. Moreover, Jolley Asset Mgmt Limited has 0.23% invested in Microsoft Corporation (NASDAQ:MSFT). Howard Cap Mngmt stated it has 4.08% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Canandaigua Bancorporation holds 115,744 shares or 1.79% of its portfolio. Van Eck owns 207,052 shares. Clifford Swan Counsel Ltd Liability Corp invested in 444,615 shares or 2.07% of the stock. Ar Asset invested 0.45% in Microsoft Corporation (NASDAQ:MSFT).

Among 37 analysts covering Microsoft Corporation (NASDAQ:MSFT), 29 have Buy rating, 2 Sell and 6 Hold. Therefore 78% are positive. Microsoft Corporation had 172 analyst reports since July 22, 2015 according to SRatingsIntel. M Partners maintained the shares of MSFT in report on Friday, July 21 with “Hold” rating. UBS maintained Microsoft Corporation (NASDAQ:MSFT) rating on Friday, July 21. UBS has “Buy” rating and $8200 target. Argus Research maintained Microsoft Corporation (NASDAQ:MSFT) rating on Tuesday, February 6. Argus Research has “Buy” rating and $107.0 target. As per Thursday, February 1, the company rating was maintained by KeyBanc Capital Markets. The stock of Microsoft Corporation (NASDAQ:MSFT) earned “Buy” rating by Morgan Stanley on Monday, June 19. The firm has “Buy” rating given on Sunday, September 17 by Cowen & Co. The stock has “Buy” rating by BMO Capital Markets on Wednesday, January 31. BMO Capital Markets maintained Microsoft Corporation (NASDAQ:MSFT) rating on Friday, October 21. BMO Capital Markets has “Outperform” rating and $69 target. On Friday, January 19 the stock rating was maintained by UBS with “Buy”. Canaccord Genuity maintained the stock with “Hold” rating in Friday, January 27 report.

Since February 16, 2018, it had 0 buys, and 3 insider sales for $930,912 activity. Shares for $325,500 were sold by Capossela Christopher C.

HCA Healthcare, Inc. (NYSE:HCA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>